nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.11.2003 | Controversies—For

FDG-PET in infectious and inflammatory disease

verfasst von: Wim J. G. Oyen, Luigi Mansi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 11/2003

Einloggen, um Zugang zu erhalten

Excerpt

Suspected focal infection or inflammation is a challenging medical problem, especially in fever of unknown origin (FUO). In 1961, Petersdorf and Beeson formulated the classical definition of FUO: an illness of more than three weeks’ duration with fever higher than 38.3°C (101°F) on several occasions, and diagnosis uncertain after one week of study in the hospital. In 1992, the requirement that the evaluation must take place in the hospital was removed and immunocompromised patients were excluded, since these patients need an entirely different diagnostic and therapeutic approach [1]. …

Petersdorf RG. Fever of unknown origin. An old friend revisited. Arch Intern Med 1992; 152:21–22.CrossRefPubMed

Tahara T, Ichiya Y, Kuwabara Y, et al. High [¹⁸F]-fluorodeoxyglucose uptake in abdominal abscesses: a PET study. J Comput Assist Tomogr 1989; 13:829–831.PubMed

Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992; 33:1972–1980.PubMed

Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point¹⁸F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43:871–875.PubMed

Lorenzen J, Buchert R, Bohuslavizki KH. Value of FDG PET in patients with fever of unknown origin. Nucl Med Commun 2001; 22:779–783.PubMed

Meller J, Altenvoerde G, Munzel U, et al. Fever of unknown origin: prospective comparison of [¹⁸F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET. Eur J Nucl Med 2000; 27:1617–1625.PubMed

Blockmans D, Knockaert D, Maes A, et al. Clinical value of¹⁸F-fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 2001; 32:191–196.CrossRefPubMed

Bleeker-Rovers CP, van der Meer JW, Corstens FH, Oyen WJ. Promising role of FDG PET in patients with fever of unknown origin. J Nucl Med 2003; 44 (Suppl):45P.

Bleeker-Rovers CP, de Kleijn EMHA, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG-PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2003; 30:in press.

10.

Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL. Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med 1998; 25:1238–1243.CrossRefPubMed

11.

Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000; 27:822–832.CrossRefPubMed

12.

Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 2003; 24:615–624.CrossRefPubMed

13.

Blockmans D, Stroobants S, Maes A, Mortelmans L. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000; 108: 246–249.CrossRefPubMed

14.

Spaepen K, Stroobants S, Verhoef G, Mortelmans L. Positron emission tomography with (F-18) FDG for therapy response monitoring in lymphoma patients. Eur J Nucl Med Mol Imaging 2003; 30 (Suppl 1):S97–S105.

Titel: FDG-PET in infectious and inflammatory disease
verfasst von: Wim J. G. Oyen
Luigi Mansi
Publikationsdatum: 01.11.2003
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 11/2003
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-003-1359-y

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2003

FDG-PET in infectious and inflammatory disease

A new, practical, low-dose 14C-urea breath test for the diagnosis of Helicobacter pylori infection: clinical validation and comparison with the standard method

Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine

Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults

Use of co-registered 11C-methionine PET and computed tomography for the localisation of parathyroid adenomas

Immunoscintigraphy of septic loosening of knee endoprosthesis: a retrospective evaluation of the antigranulocyte antibody BW 250/183